Early trial tests 'Supercharged' immune cells against skin cancer
NCT ID NCT07144384
Summary
This early-stage study is testing whether injecting two types of donor immune cells directly into skin cancer tumors is safe and can help the body fight the cancer. The trial will involve 40 adults with basal cell or squamous cell carcinoma who are already scheduled for surgical removal of their tumor. Researchers want to see if these 'natural killer' cells can persist in the tumor and potentially make treatment more effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SKIN SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ohio State University Comprehensive Cancer Center
RECRUITINGColumbus, Ohio, 43210, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.